WO2002078604A3 - Transdermal delivery of bioactive material - Google Patents

Transdermal delivery of bioactive material Download PDF

Info

Publication number
WO2002078604A3
WO2002078604A3 PCT/US2002/010086 US0210086W WO02078604A3 WO 2002078604 A3 WO2002078604 A3 WO 2002078604A3 US 0210086 W US0210086 W US 0210086W WO 02078604 A3 WO02078604 A3 WO 02078604A3
Authority
WO
WIPO (PCT)
Prior art keywords
transdermal delivery
affixed
face
matrix
bioactive material
Prior art date
Application number
PCT/US2002/010086
Other languages
French (fr)
Other versions
WO2002078604A2 (en
Inventor
Jesus Miranda
Christopher Adams
Original Assignee
Elan Transdermal Technologies
Jesus Miranda
Christopher Adams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Transdermal Technologies, Jesus Miranda, Christopher Adams filed Critical Elan Transdermal Technologies
Publication of WO2002078604A2 publication Critical patent/WO2002078604A2/en
Publication of WO2002078604A3 publication Critical patent/WO2002078604A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Abstract

A transdermal delivery device comprising a multi-phase matrix which includes a solid liquid-retaining member and associated therewith a bioactive material in liquid form, for example, a transdermal delivery device comprisinga barrier layer affixed to one face of the matrix and having an exposed face, the exposed face having affixed thereto a mounting layer, and the other face of the matrix having affixed therto a removable layer, an example of the liquid-retaining member being an absorbent material, for example, a natural or synthetic fiber gauze, a non-woven medical absorbent, a natural sponge, and a synthetic sponge.
PCT/US2002/010086 2001-03-30 2002-04-01 Transdermal delivery of bioactive material WO2002078604A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28053201P 2001-03-30 2001-03-30
US60/280,532 2001-03-30

Publications (2)

Publication Number Publication Date
WO2002078604A2 WO2002078604A2 (en) 2002-10-10
WO2002078604A3 true WO2002078604A3 (en) 2003-11-27

Family

ID=23073484

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/010086 WO2002078604A2 (en) 2001-03-30 2002-04-01 Transdermal delivery of bioactive material

Country Status (1)

Country Link
WO (1) WO2002078604A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US9248136B2 (en) 2011-11-23 2016-02-02 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9289382B2 (en) 2012-06-18 2016-03-22 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR20170005819A (en) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486362A (en) * 1991-05-07 1996-01-23 Dynagen, Inc. Controlled, sustained release delivery system for treating drug dependency

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9248136B2 (en) 2011-11-23 2016-02-02 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9289382B2 (en) 2012-06-18 2016-03-22 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion

Also Published As

Publication number Publication date
WO2002078604A2 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
WO2002078602A3 (en) Transdermal delivery of pergolide
WO2002078604A3 (en) Transdermal delivery of bioactive material
ES2118535T3 (en) PATCH CONTAINING AN ACTIVE PRINCIPLE.
BR9916886B1 (en) absorbent elastic nonwoven material, personal care absorbent article and medical absorbent article.
BR9808272A (en) Cosmetic product for application of skin actives.
DE59306283D1 (en) ACTIVE SUBSTANCE PLASTER FOR LOW-MELTING AND / OR VOLATILE ACTIVE SUBSTANCES
MXPA02005006A (en) Adhesive bandage.
BR0100564A (en) Composite structure with adhesive matrix, containing one or more assets
GB0111755D0 (en) A wound dressing
FI972004A (en) Implantable device for administering active agents to plants
DE602004009060D1 (en) CUSHION FOR SKIN CLEANSING AND SKIN HUMIDIFICATION
FR2807321B1 (en) NEW ACTIVE INGREDIENT, COMPOSITION CONTAINING THE SAME, AND USE IN COSMETICS, DERMOCOSMETICS, DERMOPHARMACY OR PHARMACY OR ON WOVEN OR NONWOVEN MEDIA
DK0865274T3 (en) Surface stabilized pharmaceutical composition for application to the skin
ES2155614T3 (en) USE OF FLAVORS AND FLAVORS TO INDUCE OR CHANGE FOOD HABITS.
TH61620A (en) Absorbent material products

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP